The target-specific cytotoxicity for gram-negative bacteria and the endotoxin-neutralizing activity of the 55-kDa bactericidal/Permeability-increasing protein (BPI) and its bioactive 23-kDa NH2-terminal fragment depend on the strong attraction of BPI for the lipid A region of lipopolysaccharides (LPS). We have shown before that smooth gram-negative bacteria with long-chain LPS are more resistant to BPI (especially holo-BPI) than are rough strains. It has been suggested that the high BPI resistance of some gram-negative bacteria, such as Proteus mirabilis, might also reflect the structural diversity of lipid A. To explore this possibility, we compared the antibacterial activity and binding of natural and recombinant holo-BPI and a recombinant NH2-terminal fragment (rBPI-23) to an isogenic rough (Re-LPS chemotype) and a smooth (S-LPS chemotype) strain ofP. mirabilis and to LPS isolated from the two strains. Holo-BPI and rBPI-23 were both potently active against the Re strain of P. mirabilis (90%o lethal dose, 20 nM). In contrast, the smooth strain was .100 times more resistant to holo-BPI but only 10 times more resistant to rBPI-23. rBPI-23 was also more potent against several Escherichia coli strains from clinical bacteremia isolates. Differences in the antibacterial potency of BPI toward the Re and S strains of P. mirabilis correlated with differences in the binding of holo-BPI and rBPI-23 to these bacteria. In contrast, the binding of biosynthetically (in vitro transcribed and translated) 35S-labeled holo-BPI and NH2-terminal fragment to isolated Re-and S-LPS from P. mirabiis in solution was similar. Moreover, in the Limulus amebocyte lysate assay, holo-BPI and rBPI-23 potently neutralized both forms of LPS with equal effectiveness. Together, these results strongly suggest that BPI recognizes Proteus lipid A and that the relative resistance of (smooth) P. mirabilis to holo-BPI is due to the inhibitory effect of long polysaccharide chains of tightly packed LPS in the envelope.
The bactericidal/permeability-increasing protein (BPI) is a ca. 55-kDa cationic antimicrobial protein located principally in the granules of polymorphonuclear leukocytes (33, 35, 38) . The apparently exclusive cytotoxicity of BPI for gramnegative bacteria is attributable to its strong attraction for (surface) envelope lipopolysaccharides (LPS), primarily the negatively charged residues within and near the lipid A region (19, 37) . The activity of BPI against a wide range of gram-negative bacteria and the demonstration that BPI binds to and neutralizes a broad spectrum of LPS species (3, 6, 21, 23) are also consistent with the belief that the primary site of interaction of BPI with LPS is the highly conserved lipid A region. However, sensitivity to BPI is quite variable among strains of Escherichia coli and Salmonella typhimurium. Resistance increases with increasing length of the LPS polysaccharide chains, which correlates with decreased binding of BPI (32, 34, 36) .
The relative resistance of gram-negative bacteria producing long-chain LPS seems to be explained by the effect of the densely packed LPS molecules in the bacterial envelope on the access of BPI to the lipid A region. The greater antibacterial potency (in comparison to holo-BPI) of the bioactive 23-to 25-kDa NH2-terminal fragment against more-resistant strains of E. coli is consistent with this interpretation (24, 34) . On the other hand, polysaccharide chain length has little or no effect on the interaction of either holo-BPI or the N-terminal fragment with isolated LPS (6, 23) , presumably because the lipid A region is more readily accessible in this presentation.
Whether additional structural determinants in the LPS molecule play a role in the very high resistance to BPI of some gram-negative bacterial species, such as Serratia marcescens and Pseudomonas cepacia, is not known (2, 9) . Thus, while the lipid A region is highly conserved among gram-negative bacteria, structural diversity has been recognized. For example, in the lipid A moiety of Proteus mirabilis LPS, an ester-linked phosphate group has been substituted by a 4-amino-4-deoxy-L-arabinopyranosyl residue (29) .
It has been proposed that this substitution may account for the resistance of this microorganism to cationic antibiotics, such as polymyxin B (12) , and antibacterial proteins, such as BPI (also called CAP 57 [26, 27] and BP 55 [9, 31] (12, 14) . All bacteria were grown overnight at 37°C in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) except for E. coli J5, which were grown in triethanolamine-buffered minimal salts medium (30) . A 50-,ul aliquot of the overnight culture was added to 5 ml of fresh medium and grown for 4 h to the late logarithmic phase. The bacteria were harvested and resuspended in sterile physiological saline to the desired concentration.
LPS. LPS was extracted from the R45 mutant of P. mirabilis with phenol-chloroform-petroleum ether (5) and purified by electrodialysis (4) . LPS from the smooth strain S1959 was extracted by the phenol-water method (39) and purified as described previously (11) . Purified LPS was monitored by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining and showed the expected differences for LPS purified from P. mirabilis R45 and S1959. The purified LPS was sonicated and diluted in a 10 mM sodium phosphate buffer (pH 7.0) for the Limulus amoebocyte lysate (LAL) assay or in phosphate-buffered saline (PBS, pH 7.4) for the LPS binding assay (see below).
BPI and BPI NH2-terminal fragment. Native human BPI (nBPI) was purified from crude polymorphonuclear leukocyte extracts as described previously (19) . Recombinant forms of human holo-BPI (rBPI) and its NH2-terminusderived fragment (rBPI-23) were generously provided by Xoma Corporation, Berkeley, Calif. (6) . In all bioassays used, the activities of nBPI and rBPI were virtually identical.
In vitro transcription and translation of BPI cDNA. The cDNA for human BPI (8) cloned downstream of the T3 polymerase promoter in plasmid pT7T3 (Pharmacia Biotech Inc., Piscataway, N.J.) was kindly provided by G. Theofan (Xoma Corporation, Santa Monica, Calif.). Since an in vitro translation system without microsomes was used, the signal sequence was deleted by excising the cDNA, in frame, between two Drall restriction sites (-25 to +12), as described by Ooi and Weiss (22) . The N terminus of the resulting translation products contained either Met- (-31 In vitro transcription was performed with an Mcap in vitro transcription kit from Stratagene (La Jolla, Calif.), for which 20 U of T3 polymerase was used for 1 ,ug of linearized DNA.
The mRNA was purified, and 7 ,ul (0.25 ,ug/,l) was added to an in vitro translation mixture that contained 49 ,ul of rabbit reticulocyte lysate, 2 ,u of RNasin (40 U/RI), 2 plA of a 1 mM amino acid mixture (without methionine), 4 pul of [35S]methionine (Dupont/New England Nuclear, Boston, Mass.) (10 mCi/ml), and 5 ,ul of diethylpyrocarbonate-treated H20. The reaction mix was incubated at 30°C. After 60 min, the samples were placed on ice to stop the reaction.
To monitor incorporation of [35S]methionine into translation products, a 1-pA aliquot of the incubation mixture was evaluated by trichloroacetic acid precipitation by the procedure described in the Promega technical manual. In addition, translation products were analyzed by SDS-PAGE and autoradiography to ensure that a single major product of the expected size was produced. An aliquot of the translation products was boiled in sample buffer containing SDS (16), run on 10 to 15% polyacrylamide gradient gels with the Pharmacia Phast Gel System, and visualized by autoradiography. T3 Chromogenic LAL assay. The ability of nBPI and rBPI-23 to inhibit the activity of isolated dispersed LPS (25 to 1,000 pg/ml) in a chromogenic LAL assay was measured as described previously (23) .
Assay of bacterial viability. Bacteria (106/ml) were incubated for 30 
RESULTS
Comparison of Re and S P. mirabilis as targets for holo-BPI and rBPI-23. (i) Growth-inhibitory activity. Figure 1A shows that P. mirabilis R45 is highly sensitive to the growthinhibitory effects of nBPI, rBPI, and rBPI-23. For each BPI species, the 50% lethal dose (LD50) is ca. 5 to 10 nM for this bacterial strain. In contrast, the smooth parent strain (P. mirabilis S1959) displayed the high level of resistance to holo-BPI (nBPI and rBPI; LD50, >1 ,M; Fig. 1B ) reported previously (27) . However, the recombinant BPI fragment (rBPI-23) exhibited potent antibacterial activity (LD5Q, -70 nM) against this more resistant strain of P. mirabilis.
(ii) Binding. We have shown previously that the antibacterial potency of BPI against various strains and species of bacteria correlates closely with binding of BPI to the bacteria (32, 34, 36) . Figure 2 shows the extent of binding of rBPI and rBPI-23 to P. mirabilis R45 and S1959. This binding parallels the antibacterial activity of the two proteins against these strains (Fig. 1) . Whereas rBPI-23 binds avidly to the deep rough strain of P. mirabilis and somewhat less well to the smooth strain, holo-BPI binds avidly to the rough strain but not appreciably to the smooth strain, even when high concentrations of holo-BPI are added (compare Fig. 2A and B, lanes 3 and 4 and lanes 6 and 7).
Comparison of antibacterial activity of holo-BPI and rBPI-23 against E. coli strains from clinical isolates. The same pattern of BPI activity was also observed among a wide range of E. coli strains, many representing strains frequently isolated from human E. coli bacteremia cases (1, 10) . Thus, holo-BPI and rBPI-23 displayed similar potent growth-inhibitory activity against a strain producing short-chain LPS (i.e., J5) (LD9Q, -10 nM; BPI than to rBPI-23. The potency of rBPI-23 was two to six times greater than that of holo-BPI against these moreresistant bacteria.
Binding of in vitro-translated holo-BPI and N-terminal fragment to immobilized LPS: inhibition by added Re-and S-LPS from P. mirabilis. In contrast to the differences in the interaction of BPI with bacteria containing long-or shortchain LPS and the differences between holo-BPI and the BPI fragment against smooth strains of gram-negative bacteria, no appreciable effect of LPS polysaccharide chain length on the interaction of either holo-BPI or the BPI fragment with isolated LPS has been observed (6, 23) . Because of the very great differences in the sensitivity of P. mirabilis R45 and S1959 to holo-BPI and in the relative activities of holo-BPI BPI-456 and rBPI-23 against P. mirabilis S1959 (Fig. 1) , we also compared the interaction of holo-BPI and the N-terminal fragment with LPS isolated from these two strains. Physical interaction between purified P. mirabilis LPS and BPI species corresponding to holo-BPI and the bioactive N-terminal fragment was measured indirectly by testing the ability of added P. mirabilis LPS to inhibit the binding of in vitro-translated 35S-labeled BPI-456 and BPI-221 to immobilized E. coli Ra LPS (see Materials and Methods). In vitro-translated 35S-labeled BPI-456 and BPI-221 bind to immobilized LPS in a manner indistinguishable from that of nBPI and rBPI-23 (unpublished data), and binding of both 35S-labeled in vitro-translated species is competitively inhibited in a nearly identical fashion by nBPI and rBPI-23 (Fig.  3) . Both the Re-and S-forms of purified P. mirabilis LPS, added in dispersed form, also competitively inhibited the binding of 35S-labeled BPI-456 and BPI-221 to immobilized LPS (Fig. 4) . Since the inhibitory effects of the two forms of dispersed Proteus LPS on the binding of the two species of BPI to immobilized E. coli Ra LPS were virtually identical, we conclude that the interaction of BPI-456 and BPI-221 with LPS isolated from P. mirabilis R45 and S1959 is not significantly different.
Comparison of LPS-neutralizing activity of nBPI-55 and rBPI-23 for P. mirabilis LPS. The ability of holo-BPI and rBPI-23 to inhibit the bioactivity of purified dispersed LPS from Re and S P. mirabilis strains was also tested. In the LAL assay, the two proteins were equipotent against the two chemotypes of LPS (Fig. 5) . Thus, in contrast to interactions with intact P. mirabilis, the interaction of the two proteins with either S-or Re-LPS was nearly the same.
DISCUSSION
The primary target of BPI is the highly conserved lipid A region of LPS (3, 6, 19, 20, 23) , enabling BPI to be effective
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Protein concentration ( against a wide array of gram-negative bacteria. The sensitivity of gram-negative bacteria to BPI varies, however, depending on polysaccharide chain length. BPI is less effective against gram-negative bacteria that produce long polysaccharide chains (Fig. 1, Table 1 ), resulting in decreased binding of BPI to these organisms (32, 34, 36) (Fig. 2) . This phenomenon has been studied extensively in E. coli and S.
typhimurium and now in P. mirabilis. We observed that the S chemotype of P. mirabilis is at least 100-fold more resistant than the Re chemotype to holo-BPI (Fig. 1) ; binding of holo-BPI to the S strain was barely detectable (Fig. 2B) (Fig. 1B) . The pronounced difference in potency between holo-BPI and rBPI-23 against the S chemotype of P. mirabilis allowed the demonstration that the difference in potency correlates with differences in binding to intact bacteria ( Fig. 1 and 2 ). Despite the great difference in potency between BPI and rBPI-23 against smooth P. mira-S1959 LPS (Fig. 1) , the interactions of holo-BPI and the NH2-terminal fragment with purified LPS from this strain were virtually identical (Fig. 4 and 5) .
It has been suggested that P. mirabilis is resistant to BPI (also called CAP 57 [26, 27] and BP 55 [9, 31] We believe that a critical determinant of BPI interaction with its target site is the presentation of the LPS molecule. LPS is tightly packed in the outer membrane of gramnegative bacteria (15) . In this setting, the presence of long (flexible) polysaccharide chains may act as an umbrella (13) (Fig. 6 ) to shield the anionic and hydrophobic sites in and near the lipid A region from interaction with complementary cationic and amphipathic regions within the N-terminal half of BPI (8, 24) . Presumably, the smaller size of the N-terminal BPI fragment allows it to traverse this steric barrier more readily than holo-BPI. Isolated, dispersed LPS may exist in several different conformations, such as isolated molecules, micelles, or bilayered structures (15, 18) . We have shown in this study (Fig. 4 and 5 ) and previously (6, 23) that holo-BPI and the N-terminal fragment interact with isolated dispersed LPS similarly regardless of polysaccharide chain length. We speculate that it is the looser packing of LPS in these assemblies (Fig. 6 ) that permits equal access of holo-BPI and its N-terminal fragment to the target site(s) when LPS is presented in this manner.
The systematic comparison of the action of holo-BPI and BPI fragment on intact bacteria and purified LPS from isogenic Re and S strains of P. mirabilis has clarified the basis of resistance (and sensitivity) of these gram-negative bacteria to BPI. Similar studies comparing the interaction of BPI with apparently highly resistant bacteria, such as S. marcescens and P. cepacia, and the interaction of BPI with isolated LPS from the same organism may aid in revealing the basis of resistance of these organisms to BPI.
